SCOPUS 정보 검색 플랫폼

ecancermedicalscience

Volumn 4, Issue 1, 2010, Pages

Safe practice and nursing care of patients receiving oral anti-cancer medicines: A position statement from UKONS

(6) Oakley, C a Lennan, E b Roe, H c Craven, O d Harrold, K e Vidall, C f

a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST (United Kingdom)

b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST (United Kingdom)

c Lillyhall Business Centre (United Kingdom)

d CHRISTIE HOSPITAL (United Kingdom)

e MOUNT VERNON CANCER CENTRE (United Kingdom)

f Healthcare at Home (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CAPECITABINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; ERLOTINIB; ETOPOSIDE; EVEROLIMUS; GEFITINIB; HYDROXYUREA; IDARUBICIN; IMATINIB; LAPATINIB; LENALIDOMIDE; MELPHALAN; METHOTREXATE; NAVELBINE; SORAFENIB; SUNITINIB; TEGAFUR; THALIDOMIDE; TOPOTECAN;

CANCER CHEMOTHERAPY; HUMAN; MOUTH CANCER; NURSE TRAINING; NURSING CARE; NURSING PRACTICE; NURSING PROTOCOL; ONCOLOGY NURSING; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; PATIENT MONITORING; PRESCRIPTION; REVIEW;

EID: 80054716851 PISSN: None EISSN: 17546605 Source Type: Journal
DOI: 10.3332/ecancer.2010.177 Document Type: Review

Times cited : (10)

References (18)

1
- 77954850776
- National Patient Safety Agency (NPSA/2008/ RRR001) London
- National Patient Safety Agency (2008) Risks of Incorrect Dosing of Oral Anti-Cancer Medicines (NPSA/2008/ RRR001) London
- (2008) Risks of Incorrect Dosing of Oral Anti-Cancer Medicines

2
- 31544437749
- A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer
- PMID: 16344278 10.1093/annonc/mdj023
- Twelves C, Gollins S, Grieve R and Samuel L (2006) A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer Ann Oncol 17 239-45 PMID: 16344278 10.1093/annonc/mdj023
- (2006) Ann Oncol , vol.17 , pp. 239-245
- Twelves, C.¹ Gollins, S.² Grieve, R.³ Samuel, L.⁴

3
- 33751420404
- Department of Health London: Department of Health
- Department of Health (2004) Manual for Cancer Services (London: Department of Health)
- (2004) Manual for Cancer Services

4
- 55049134731
- Management of oral anticancer therapies
- Williamson S (2008) Management of oral anticancer therapies Pharm J 281 399-402
- (2008) Pharm J , vol.281 , pp. 399-402
- Williamson, S.¹

5
- 33847692398
- Oral chemotherapy safety practices at US cancer centres: Questionnaire survey
- PMID: 17223629 10.1136/bmj.39069.489757.55
- Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN and Connor M (2007) Oral chemotherapy safety practices at US cancer centres: questionnaire survey BMJ 334 407 PMID: 17223629 10.1136/bmj.39069. 489757.55
- (2007) BMJ , vol.334 , pp. 407
- Weingart, S.N.¹ Flug, J.² Brouillard, D.³ Morway, L.⁴ Partridge, A.⁵ Bartel, S.⁶ Shulman, L.N.⁷ Connor, M.⁸

6
- 77954838529
- Development of a patient held diary Cancer
- Oakley C, Johnson J and Deeprose M (2008) Development of a patient held diary Cancer Nurs Pract 7 31-4
- (2008) Nurs Pract , vol.7 , pp. 31-34
- Oakley, C.¹ Johnson, J.² Deeprose, M.³

7
- 80054773069
- London
- (2008) National Confidential Enquiry into Patient Outcome and Death: For Better, For Worse? A Review of the Care of Patients Who Died Within 30 days of Receiving Systemic Anti-Cancer Therapy (London)
- (2008) National Confidential Enquiry into Patient Outcome and Death: for Better, for Worse? A Review of the Care of Patients Who Died Within 30 Days of Receiving Systemic Anti-Cancer Therapy

8
- 70349214648
- National Chemotherapy Advisory Group London
- National Chemotherapy Advisory Group (2009) Chemotherapy Services in England: Ensuring Quality and Safety (London)
- (2009) Chemotherapy Services in England: Ensuring Quality and Safety

9
- 1842854015
- Position statement on care of patients receiving oral anticancer drugs
- British Oncology Pharmacy Association (BOPA)
- British Oncology Pharmacy Association (BOPA) (2004) Position statement on care of patients receiving oral anticancer drugs Pharm J 272 422-3
- (2004) Pharm J , vol.272 , pp. 422-423

10
- 39749121020
- Department of Health London
- Department of Health (2007) Cancer Reform Strategy (London)
- (2007) Cancer Reform Strategy

11
- 77954854305
- A survey of therapy areas in which nurses prescribe and CPD needs
- Courtenay M and Gordon J (2009) A survey of therapy areas in which nurses prescribe and CPD needs Nurse Prescribing 7 255-62
- (2009) Nurse Prescribing , vol.7 , pp. 255-262
- Courtenay, M.¹ Gordon, J.²

12
- 74949086115
- Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: A randomized, controlled trial
- PMID: 19917849 10.1200/JCO.2008.20.6755
- Molassiotis A, Brearley S, Saunders M, Craven O, Wardley A, Farrell C, Swindell R, Todd C and Luker K (2009) Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial J Clin Oncol 27 6191-8 PMID: 19917849 10.1200/JCO.2008.20.6755
- (2009) J Clin Oncol , vol.27 , pp. 6191-6198
- Molassiotis, A.¹ Brearley, S.² Saunders, M.³ Craven, O.⁴ Wardley, A.⁵ Farrell, C.⁶ Swindell, R.⁷ Todd, C.⁸ Luker, K.⁹

13
- 77954839045
- Health and Safety Executive London: HSE
- Health and Safety Executive (2003) Safe Handling of Cytotoxic Drugs (London: HSE)
- (2003) Safe Handling of Cytotoxic Drugs

14
- 80054719703
- Available from: accessed January 2010
- Multinational Association for Supportive Care in Cancer MASCC Oral Agent Teaching Tool (MOATT) Available from: http://www.mascc.org/mc/page.do? sitePageId=89760 (accessed January 2010)

15
- 80054745899
- Raising awareness of neutropenic sepsis risk in ambulatory patients Cancer
- Higgins A (2008) Raising awareness of neutropenic sepsis risk in ambulatory patients Cancer Nurs Pract 7 34-8
- (2008) Nurs Pract , vol.7 , pp. 34-38
- Higgins, A.¹

16
- 33644914199
- Obtaining consent for chemotherapy
- British Committee for Standards in Haematology PMID: 16445827 10.1111/j.1365-2141.2005.05874.x
- Treleaven J, Cullis JO, Maynard R, Bishop E, Ainsworth-Smith I, Roques A, Webb A, Favre J and Milligan D; British Committee for Standards in Haematology (2006) Obtaining consent for chemotherapy Br J Haematol 132 552-9 PMID: 16445827 10.1111/j.1365-2141.2005.05874.x
- (2006) Br J Haematol , vol.132 , pp. 552-559
- Treleaven, J.¹ Cullis, J.O.² Maynard, R.³ Bishop, E.⁴ Ainsworth-Smith, I.⁵ Roques, A.⁶ Webb, A.⁷ Favre, J.⁸ Milligan, D.⁹

17
- 0037152667
- Oral cancer treatment: Developments in chemotherapy and beyond
- PMID: 12434279 10.1038/sj.bjc.6600591
- O'Neill VJ and Twelves CJ (2002) Oral cancer treatment: developments in chemotherapy and beyond Br J Cancer 87 933-7 PMID: 12434279 10.1038/sj.bjc. 6600591
- (2002) Br J Cancer , vol.87 , pp. 933-937
- O'Neill, V.J.¹ Twelves, C.J.²

18
- 68149100864
- London: BMJ Group and RPS Publishing
- British National Formulary (2009) 58 (London: BMJ Group and RPS Publishing)
- (2009) British National Formulary , pp. 58

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.